Back to Search
DAVID CHERNG, DO
DO
Family Medicine Physician
NPI: 1528718798IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2022
Research & Publications (5)
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
PMID 17389292·Arch Intern Med·2007
2-rct
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.
PMID 16760795·J Acquir Immune Defic Syndr·2006
2-rct
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
PMID 15097300·J Acquir Immune Defic Syndr·2004
3-trial
Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.
PMID 12001058·J Infect Dis·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 31700 TEMECULA PKWY STE 1
TEMECULA, CA 92592 - Phone
- (951) 331-2527
Quick Facts
- NPI
- 1528718798
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 4
- Publications
- 5
Are you this provider?
Claim Your Profile